WEST PHARMACEUTICAL SERVICES, INC. Cost of Revenue
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Cost of Revenue of $543.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $543.10M, a 10.25% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $548.50M, a 17.68% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $501.10M, a 5.45% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $510.30M, a 5.83% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for fiscal 2025 was $1.97B, a 3.98% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for fiscal 2024 was $1.89B, a 4.07% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for fiscal 2023 was $1.82B, a 3.99% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. cost of goods and services sold for fiscal 2022 was $1.75B, a 5.73% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $543.10M 10-Q · filed 2026-07-23 | $1.09B 10-Q · filed 2026-07-23 | $1.59B derived: sum of 3 quarters · filed 2026-07-23 | $2.10B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $548.50M 10-Q · filed 2026-04-23 | $1.05B derived: sum of 2 quarters · filed 2026-04-23 | $1.56B derived: sum of 3 quarters · filed 2026-04-23 | $2.05B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | $501.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.01B derived: sum of 2 quarters · filed 2026-02-17 | $1.50B derived: sum of 3 quarters · filed 2026-07-23 | $1.97B 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $510.30M 10-Q · filed 2025-10-23 | $1.00B derived: sum of 2 quarters · filed 2026-07-23 | $1.47B 10-Q · filed 2025-10-23 | $1.94B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $492.60M 10-Q · filed 2026-07-23 | $958.70M 10-Q · filed 2026-07-23 | $1.43B derived: sum of 3 quarters · filed 2026-07-23 | $1.92B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $466.10M 10-Q · filed 2026-04-23 | $941.30M derived: sum of 2 quarters · filed 2026-04-23 | $1.42B derived: sum of 3 quarters · filed 2026-04-23 | $1.90B derived: sum of 4 quarters · filed 2026-04-23 | ||||
| 2024-12-31 | $475.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $957.40M derived: sum of 2 quarters · filed 2026-02-17 | $1.43B derived: sum of 3 quarters · filed 2026-02-17 | $1.89B 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $482.20M 10-Q · filed 2025-10-23 | $954.30M derived: sum of 2 quarters · filed 2025-10-23 | $1.42B 10-Q · filed 2025-10-23 | $1.87B derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $472.10M 10-Q · filed 2025-07-24 | $937.30M 10-Q · filed 2025-07-24 | $1.39B derived: sum of 3 quarters · filed 2026-02-17 | $1.85B derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $465.20M 10-Q · filed 2025-04-24 | $919.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.38B derived: sum of 3 quarters · filed 2026-02-17 | $1.84B derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $453.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $912.90M derived: sum of 2 quarters · filed 2026-02-17 | $1.38B derived: sum of 3 quarters · filed 2026-02-17 | $1.82B 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $459.10M 10-Q · filed 2024-10-24 | $921.50M derived: sum of 2 quarters · filed 2024-10-24 | $1.37B 10-Q · filed 2024-10-24 | $1.81B derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $462.40M 10-Q · filed 2024-07-25 | $907.70M 10-Q · filed 2024-07-25 | $1.35B derived: sum of 3 quarters · filed 2025-02-18 | $1.77B derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $445.30M 10-Q · filed 2024-04-25 | $891.90M derived: sum of 2 quarters · filed 2025-02-18 | $1.31B derived: sum of 3 quarters · filed 2025-02-18 | $1.76B derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $446.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $865.50M derived: sum of 2 quarters · filed 2025-02-18 | $1.32B derived: sum of 3 quarters · filed 2025-02-18 | $1.75B 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $418.90M 10-Q · filed 2023-10-26 | $868.70M derived: sum of 2 quarters · filed 2023-10-26 | $1.30B 10-Q · filed 2023-10-26 | $1.73B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $449.80M 10-Q · filed 2023-07-27 | $885.20M 10-Q · filed 2023-07-27 | $1.32B derived: sum of 3 quarters · filed 2024-02-20 | $1.73B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $435.40M 10-Q · filed 2023-04-27 | $865.60M derived: sum of 2 quarters · filed 2024-02-20 | $1.28B derived: sum of 3 quarters · filed 2024-02-20 | $1.69B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $430.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $848.50M derived: sum of 2 quarters · filed 2024-02-20 | $1.26B derived: sum of 3 quarters · filed 2024-02-20 | $1.66B 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $418.30M 10-Q · filed 2022-10-27 | $826.80M derived: sum of 2 quarters · filed 2022-10-27 | $1.23B 10-Q · filed 2022-10-27 | $1.59B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $408.50M 10-Q · filed 2022-07-28 | $807.30M 10-Q · filed 2022-07-28 | $1.18B derived: sum of 3 quarters · filed 2023-02-21 | $1.53B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $398.80M 10-Q · filed 2022-04-28 | $767.90M derived: sum of 2 quarters · filed 2023-02-21 | $1.12B derived: sum of 3 quarters · filed 2023-02-21 | $1.45B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $369.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $722.50M derived: sum of 2 quarters · filed 2023-02-21 | $1.05B derived: sum of 3 quarters · filed 2023-02-21 | $1.38B 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $353.40M 10-Q · filed 2021-10-28 | $685.50M derived: sum of 2 quarters · filed 2021-10-28 | $1.01B 10-Q · filed 2021-10-28 | $1.33B derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $332.10M 10-Q · filed 2021-07-30 | $656.60M 10-Q · filed 2021-07-30 | $974.00M derived: sum of 3 quarters · filed 2022-02-22 | $1.28B derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $324.50M 10-Q · filed 2021-04-30 | $641.90M derived: sum of 2 quarters · filed 2022-02-22 | $950.20M derived: sum of 3 quarters · filed 2022-02-22 | $1.26B derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | $317.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $625.70M derived: sum of 2 quarters · filed 2022-02-22 | $937.50M derived: sum of 3 quarters · filed 2022-02-22 | $1.23B 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $308.30M 10-Q · filed 2020-10-23 | $620.10M derived: sum of 2 quarters · filed 2020-10-23 | $916.80M 10-Q · filed 2020-10-23 | $1.21B derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $311.80M 10-Q · filed 2020-07-24 | $608.50M 10-Q · filed 2020-07-24 | $897.80M derived: sum of 3 quarters · filed 2021-02-23 | $1.19B derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $296.70M 10-Q · filed 2020-04-24 | $586.00M derived: sum of 2 quarters · filed 2021-02-23 | $882.10M derived: sum of 3 quarters · filed 2021-02-23 | $1.19B derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $289.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $585.40M derived: sum of 2 quarters · filed 2021-02-23 | $890.70M derived: sum of 3 quarters · filed 2021-02-23 | $1.17B 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $296.10M 10-Q · filed 2019-10-29 | $601.40M derived: sum of 2 quarters · filed 2019-10-29 | $882.70M 10-Q · filed 2019-10-29 | $1.17B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $305.30M 10-Q · filed 2019-07-29 | $586.60M 10-Q · filed 2019-07-29 | $873.60M derived: sum of 3 quarters · filed 2020-02-24 | $1.15B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $281.30M 10-Q · filed 2019-05-08 | $568.30M derived: sum of 2 quarters · filed 2020-02-24 | $841.40M derived: sum of 3 quarters · filed 2020-02-24 | $1.11B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $287.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $560.10M derived: sum of 2 quarters · filed 2020-02-24 | $832.70M derived: sum of 3 quarters · filed 2020-02-24 | $1.09B 10-K · filed 2020-02-24 | $1.09B 10-K · filed 2018-02-26 | |||
| 2017-09-30 | $273.10M 10-Q · filed 2018-10-30 | $273.20M 10-Q · filed 2017-10-31 | $545.70M derived: sum of 2 quarters · filed 2018-10-30 | $799.20M 10-Q · filed 2018-10-30 | $799.40M 10-Q · filed 2017-10-31 | $1.06B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $272.60M 10-Q · filed 2018-07-31 | $526.10M 10-Q · filed 2018-07-31 | $526.20M 10-Q · filed 2017-08-01 | $784.70M derived: sum of 3 quarters · filed 2019-02-28 | $1.04B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $253.50M 10-Q · filed 2018-05-08 | $253.60M 10-Q · filed 2017-05-05 | $512.10M derived: sum of 2 quarters · filed 2019-02-28 | $767.70M derived: sum of 3 quarters · filed 2019-02-28 | $1.02B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $258.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $514.20M derived: sum of 2 quarters · filed 2019-02-28 | $768.90M derived: sum of 3 quarters · filed 2019-02-28 | $1.01B 10-K · filed 2019-02-28 | $1.01B 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $255.60M 10-Q · filed 2017-10-31 | $510.30M derived: sum of 2 quarters · filed 2017-10-31 | $749.10M 10-Q · filed 2017-10-31 | $989.20M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $254.70M 10-Q · filed 2017-08-01 | $493.50M 10-Q · filed 2017-08-01 | $733.60M derived: sum of 3 quarters · filed 2018-02-26 | $969.80M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $238.80M 10-Q · filed 2017-05-05 | $478.90M derived: sum of 2 quarters · filed 2018-02-26 | $715.10M derived: sum of 3 quarters · filed 2018-02-26 | $956.60M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $240.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $476.30M derived: sum of 2 quarters · filed 2018-02-26 | $717.80M derived: sum of 3 quarters · filed 2018-02-26 | $944.00M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $236.20M 10-Q · filed 2016-10-31 | $477.70M derived: sum of 2 quarters · filed 2016-10-31 | $703.90M 10-Q · filed 2016-10-31 | $944.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $241.50M 10-Q · filed 2016-08-01 | $467.70M 10-Q · filed 2016-08-01 | $707.80M derived: sum of 3 quarters · filed 2017-02-28 | $953.80M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $226.20M 10-Q · filed 2016-05-06 | $466.30M derived: sum of 2 quarters · filed 2017-02-28 | $712.30M derived: sum of 3 quarters · filed 2017-02-28 | $959.40M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $240.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $486.10M derived: sum of 2 quarters · filed 2017-02-28 | $733.20M derived: sum of 3 quarters · filed 2017-02-28 | $973.60M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $246.00M 10-Q · filed 2015-11-02 | $493.10M derived: sum of 2 quarters · filed 2015-11-02 | $733.50M 10-Q · filed 2015-11-02 | $969.60M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $247.10M 10-Q · filed 2015-08-03 | $487.50M 10-Q · filed 2015-08-03 | $723.60M derived: sum of 3 quarters · filed 2016-02-26 | $959.90M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $240.40M 10-Q · filed 2015-05-06 | $476.50M derived: sum of 2 quarters · filed 2016-02-26 | $712.80M derived: sum of 3 quarters · filed 2016-02-26 | $946.40M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $236.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $472.40M derived: sum of 2 quarters · filed 2016-02-26 | $706.00M derived: sum of 3 quarters · filed 2016-02-26 | $933.70M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $236.30M 10-Q · filed 2014-11-03 | $469.90M derived: sum of 2 quarters · filed 2014-11-03 | $697.60M 10-Q · filed 2014-11-03 | $921.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $233.60M 10-Q · filed 2014-08-01 | $461.30M 10-Q · filed 2014-08-01 | $685.30M derived: sum of 3 quarters · filed 2015-02-25 | $898.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $227.70M 10-Q · filed 2014-05-08 | $451.70M derived: sum of 2 quarters · filed 2015-02-25 | $665.10M derived: sum of 3 quarters · filed 2015-02-25 | $891.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $224.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $437.40M derived: sum of 2 quarters · filed 2015-02-25 | $663.50M derived: sum of 3 quarters · filed 2015-02-25 | $878.70M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | $213.40M 10-Q · filed 2013-11-04 | $439.50M derived: sum of 2 quarters · filed 2013-11-04 | $654.70M 10-Q · filed 2013-11-04 | $864.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $226.10M 10-Q · filed 2013-08-05 | $441.30M 10-Q · filed 2013-08-05 | $651.40M derived: sum of 3 quarters · filed 2014-02-27 | $863.60M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $215.20M 10-Q · filed 2013-05-06 | $425.30M derived: sum of 2 quarters · filed 2014-02-27 | $637.50M derived: sum of 3 quarters · filed 2014-02-27 | $860.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $210.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $422.30M derived: sum of 2 quarters · filed 2014-02-27 | $645.60M derived: sum of 3 quarters · filed 2014-02-27 | $853.00M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $212.20M 10-Q · filed 2012-11-05 | $435.50M derived: sum of 2 quarters · filed 2012-11-05 | $642.90M 10-Q · filed 2012-11-05 | $841.70M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $223.30M 10-Q · filed 2012-08-06 | $430.70M 10-Q · filed 2012-08-06 | $629.50M derived: sum of 3 quarters · filed 2013-02-27 | $826.20M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $207.40M 10-Q · filed 2012-05-04 | $406.20M derived: sum of 2 quarters · filed 2013-02-27 | $602.90M derived: sum of 3 quarters · filed 2013-02-27 | $801.50M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $198.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $395.50M derived: sum of 2 quarters · filed 2013-02-27 | $594.10M derived: sum of 3 quarters · filed 2013-02-27 | $786.60M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $196.70M 10-Q · filed 2011-11-07 | $395.30M derived: sum of 2 quarters · filed 2011-11-07 | $587.80M 10-Q · filed 2011-11-07 | $797.30M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-06-30 | $198.60M 10-Q/A · filed 2011-08-08 | $391.10M 10-Q/A · filed 2011-08-08 | $600.60M derived: sum of 3 quarters · filed 2012-03-01 | $787.80M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-03-31 | $192.50M 10-Q · filed 2011-05-05 | $402.00M derived: sum of 2 quarters · filed 2012-03-01 | $589.20M derived: sum of 3 quarters · filed 2012-03-01 | $771.50M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2009-12-31 | $209.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $396.70M derived: sum of 2 quarters · filed 2012-03-01 | $579.00M derived: sum of 3 quarters · filed 2012-03-01 | $752.10M 10-K/A · filed 2012-03-01 | ||||
| 2009-09-30 | $187.20M 10-Q · filed 2010-11-05 | $369.50M derived: sum of 2 quarters · filed 2010-11-05 | $542.60M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $182.30M 10-Q · filed 2010-08-05 | $355.40M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $748.50M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |